- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01369524
Effect of Fluid Resuscitation and Microcirculation
June 8, 2011 updated by: Medical Centre Leeuwarden
Evaluation of Effect of Fluid Resuscitation on Sublingual Microcirculation by SDF Imaging in Intensive Care Patients, a Pilot Study
Although the investigators take many measurements to monitor the fluid state of the patients, it is not known exactly whether the fluid has real effect on the organ perfusion.
The main focus of fluid is to improve the organ perfusion.
Recent research has focused on the investigation of sublingual microcirculatory alterations.
Study Overview
Status
Completed
Conditions
Detailed Description
Is fluid responsiveness, what means a better cardiac output, equal to the need for fluid for a better organ perfusion?
In hospital the investigators are now looking to the pump function of the heart, as there is not a better measurement.
However this gives no information about necessity of giving fluids.
A healthy volunteer also gives a better pump function of the heart after fluid, but that fluid is not necessary and gives no better organ perfusion.
The question is: How many percent of the patients have a MFI score of < 2.6, when the doctor on clinical basis plans to give fluid to the patient, improves organ perfusion after fluid, and is this correlated with an improvement of the cardiac output All intensive care patients who need extra fluid are eligible for this study.
Before and after the fluid challenge we do SDF imaging sublingual.
Per patient the investigators do this 1x in 24 hours.
Concurrently, data on both patient characteristics (e.g.
severity of illness) will be obtained Study population max 100 patients.
Possible outcome: MFI < 2,6 en SV > 10% + MFI up MFI < 2,6 en SV equal + MFI equal MFI < 2,6 en SV > 10% + MFI equal MFI < 2,6 en SV equal + MFI up MFI > 2,6 en SV > 10% + MFI up MFI > 2,6 en SV equal + MFI equal MFI > 2,6 en SV > 10% + MFI equal MFI > 2,6 en SV equal + MFI up
Study Type
Observational
Enrollment (Actual)
50
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Leeuwarden, Netherlands, 8934 AD
- Medical Centre Leeuwarden
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Probability Sample
Study Population
All patients admitted on the ICU and a need of fluids
Description
Inclusion Criteria:
- age > 18
- hemodynamic monitoring
- informed consent
- admission on ICU
Exclusion Criteria:
- no informed consent
- oral surgery
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
|---|
|
ICUpatient with need of fluid
age > 18 - haemodynamic monitoring - informed consent - admission on ICU
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
correlation between change in microvascular flow index and fluid responsiveness - delta MFI before and after fluid challenge correlated to fluid responsiveness
Time Frame: 24 hours
|
24 hours
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
change in capillary density correlated to fluid responsiveness
Time Frame: 24 hours
|
24 hours
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Christiaan Boerma, MD, Medical Centre Leeuwarden
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
January 1, 2011
Primary Completion (Actual)
March 1, 2011
Study Completion (Actual)
May 1, 2011
Study Registration Dates
First Submitted
May 31, 2011
First Submitted That Met QC Criteria
June 8, 2011
First Posted (Estimate)
June 9, 2011
Study Record Updates
Last Update Posted (Estimate)
June 9, 2011
Last Update Submitted That Met QC Criteria
June 8, 2011
Last Verified
May 1, 2011
More Information
Terms related to this study
Other Study ID Numbers
- TPO 732
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Total Fluid Volume Increased
-
Yuanyuan ZhangTianjin First Central Hospital; Tianjin Union Medical CenterCompletedTotal Fluid Volume IncreasedChina
-
Rajiv Gandhi Cancer Institute & Research Center...Completed
-
Charite University, Berlin, GermanyUnknown
-
Tanta UniversityCompleted
-
Kati JärveläFinnish Cultural FoundationCompletedFluid Volume DisorderFinland
-
McGill University Health Centre/Research Institute...UnknownActual Impaired Fluid Volume
-
University of WashingtonEunice Kennedy Shriver National Institute of Child Health and Human Development...CompletedDiurnal Residual Limb Fluid Volume FluctuationUnited States
-
Universitätsklinikum Hamburg-EppendorfCompletedFluid Overload | Bloodpressure | Volume Overload | Hemodynamic Rebound
-
Università degli Studi di FerraraUnknownMechanical Ventilation Complication | Actual Impaired Fluid VolumeItaly
-
Ain Shams UniversityCompletedIntraoperative Fluid Volume | Inferior Vena Cava DiameterEgypt